A recent study, demonstrates that TP53 missense mutations generates immune-excluded tumor microenvironments in pancreatic ductal adenocarcinoma (PDCA) mouse model, these findings correlate with clinical data in PDAC patients with a poor survival outcome (84). The gene discussed is TP53; the disease is neoplasm.